TickerFiles

Arcturus Therapeutics Holdings Inc. 10-Q filing

Filed 2025-11-12 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001193125-25-275758
Form type
10-Q
CIK
0001768224
Primary document
https://www.sec.gov/Archives/edgar/data/1768224/000119312525275758/arct-20250930.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Arcturus Therapeutics Holdings Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$74.8M--
Operating Income$-45.0M--
Net Income$-36.7M--
Eps Basic-1.35--
Eps Diluted-1.35--
Cash And Equivalents$180.4M--
Total Assets$282.3M--
Total Liabilities$57.8M--
Shareholders Equity$224.6M--
Operating Cash Flow$-58.0M--
Capital Expenditures$318,000--